Unveiling the allosteric inhibition mechanism of SARS-CoV-2 main protease and discovery of a novel allosteric inhibitor
Drug Discoveries & Therapeutics · 2026
DOI: 10.5582/ddt.2026.01050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Discoveries & Therapeutics, 2026. Verfasst von Quanling Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Antiviral Agents, Protease Inhibitors. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Qingdao, China.
- Shandong Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao University, Qingdao, China.
Zitieren
APA
Zhang, Q., Wen, T., Li, M., & Tang, X. (2026). Unveiling the allosteric inhibition mechanism of SARS-CoV-2 main protease and discovery of a novel allosteric inhibitor. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2026.01050
Vancouver
Zhang Q, Wen T, Li M, Tang X. Unveiling the allosteric inhibition mechanism of SARS-CoV-2 main protease and discovery of a novel allosteric inhibitor. Drug Discoveries & Therapeutics. 2026. doi:10.5582/ddt.2026.01050
BibTeX
@article{Zhang2026,
author = {Zhang, Quanling and Wen, Tingting and Li, Mengsi and Tang, Xiaowen},
title = {Unveiling the allosteric inhibition mechanism of SARS-CoV-2 main protease and discovery of a novel allosteric inhibitor},
journal = {Drug Discoveries & Therapeutics},
year = {2026},
doi = {10.5582/ddt.2026.01050}
}
EUVIMED